Pokka Corporation

Kitanagoya, Japan

Pokka Corporation

Kitanagoya, Japan
SEARCH FILTERS
Time filter
Source Type

An anti-avian influenza virus agent containing, as an active ingredient, a component obtained when a guava extract extracted from a guava with an extraction solvent consisting primarily of at least one of water and a hydrophilic organic solvent is subjected to fractionation by HPLC under specific conditions. The specific conditions include the use of an ODS column, the use of a water-methanol mixture having a methanol concentration of 20% as a mobile phase during a period until 15 minutes after applying the guava extract to the column, and the use of a water-methanol mixture having a methanol concentration of 40% as a mobile phase during a subsequent period of 15 to 30 minutes. Alternatively, the specific conditions further include the use of a water-methanol mixture having a methanol concentration of 60% as a mobile phase during a period of 30 to 45 minutes after applying the guava extract to the column. The component contained in the anti-avian influenza virus agent is eluted from the column in a period until 20 minutes after applying the guava extract to the column or in a subsequent period of 20 to 35 minutes.


Patent
Pokka Corporation | Date: 2012-04-20

Provided is a cream composition superior in handleability. The cream composition contains milk fat, a sugar, and water. The content of the milk fat is more than 5 mass % and 30 mass % or less. The content of the sugar is 40 to 65 mass %. The median diameter of the cream composition is 0.2 to 4.0 m, and the viscosity of the cream composition at 20 C. is 100 to 2,500 mPas.


Patent
Incorporated Administrative Agency National Agriculture And Food Research Organization, Pokka Corporation and Iwata Pokka Foods Co. | Date: 2013-04-10

A granulating method is a method in which powder containing a water-soluble component is granulated. In the disclosed granulating method, a dispersion element, wherein fine water droplets are dispersed in superheated steam, is expelled from a nozzle, and thus the dispersion element and powder in a flowing state come into contact with one another. It is preferable that the mass ratio of superheated steam contained in the dispersion element, as a mass ratio found from the theoretical flow amount of superheated steam expelled from the nozzle, and the actual flow amount of water supplied to the nozzle, be set in a range of 20-70 mass%.


An anti-methicillin-resistant Staphylococcus aureus agent (anti-MRSA agent) and an anti-vancomycin-resistant Enterococcus agent (anti-VRE agent) contain as an active ingredient an Oobagi extract extracted from Oobagi with an extraction solvent including at least an organic solvent. Alternatively, the anti-MRSA agent and the anti-VRE agent contain as an active ingredient at least one selected from nymphaeol-A, nymphaeol-B, and nymphaeol-C.


A convertible writing instrument can be put into either a compact capped configuration, 3 to 4 inches in length, or an extended writing configuration, 5 to 6 inches in length. A relatively elongated cap, which covers most of the relatively shortened pen member in the compact configuration, can be re-attached to the back of the pen, so as to lengthen the instrument in preparation for writing. Multiple interchangeable caps and rear modules can be coupled to the pen member to provide a variety of appearances and functions.


Patent
Pokka Corporation | Date: 2010-05-19

Each of an antioxidant, an antimicrobial agent, an antitumor agent, a food and beverage product, cosmetics, a quasi-drug and a pharmaceutical of the present invention contains a new flavanone compound represented by the following structural formula:


Provided is a method for analyzing a dispersion made by dispersing a liquid or solid dispersoid into a liquid dispersion medium. The method includes the steps of: preparing a sample liquid from the dispersion by forming an agglomerate of the dispersoid in the dispersion medium; redispersing the dispersoid that forms the agglomerate in the sample liquid into the dispersion medium of the sample liquid; and measuring the amount of the dispersoid that has been redispersed from the agglomerate in the sample liquid.


Methods of use of an anti-methicillin-resistant Staphylococcus aureus agent (anti-MRSA agent) and an anti-vancomycin-resistant Enterococcus agent (anti-VRE agent) contain as an active ingredient a Macaranga tanarius extract extracted from Macaranga tanarius with an extraction solvent including at least an organic solvent are disclosed. The anti-MRSA agent and the anti-VRE agent contain as an active ingredient at least one selected from nymphaeol-A, nymphaeol-B, and nymphaeol-C.


A periodontal bacterial growth inhibitor contains as an active ingredient a Macaranga tanarius extract extracted from Macaranga tanarius with an extraction solvent including at least an organic solvent. Alternatively, the periodontal bacterial growth inhibitor contains as an active ingredient at least one selected from nymphaeol-A, nymphaeol-B, and nymphaeol-C. The periodontal bacterial growth inhibitor is used by being blended to, for example, an oral hygiene product or a food and drink.


A periodontal bacterial growth inhibitor contains as an active ingredient a Macaranga tanarius extract extracted from Macaranga tanarius with an extraction solvent including at least an organic solvent. Alternatively, the periodontal bacterial growth inhibitor contains as an active ingredient at least one selected from nymphaeol-A, nymphaeol-B, and nymphaeol-C. The periodontal bacterial growth inhibitor is used by being blended to, for example, an oral hygiene product or a food and drink.

Loading Pokka Corporation collaborators
Loading Pokka Corporation collaborators